Skip to content
Review Open access

Implication of orexin transmission in chronic stress, hyperarousal, and neuroplasticity deficits: a mechanistic framework for depression and anxiety

Sep 2026 · Frontiers in Psychiatry · Vol 17 · 0 citations · 104 references
Medicine

TL;DR

A mechanistic framework in which CRF-mediated recruitment of hypothalamic OX neurons contributes to neuroplasticity deficits in the mPFC, HIPP, and AMY is proposed, which positions OX transmission as a potential link between chronic stress and mood-related psychopathology.

Abstract

Stress is a major risk factor for depression- and anxiety-related disorders and produces neuroplastic adaptations within brain regions that regulate emotion, cognition, and stress responsivity. These adaptations include dendritic retraction in the medial prefrontal cortex (mPFC), suppression of plasticity and neurogenesis in the hippocampus (HIPP), and hypertrophic remodeling of circuits within the amygdala (AMY), promoting emotional dysregulation and maladaptive behavior. Although these alterations are well-documented, the mechanisms that coordinate their emergence across multiple neural systems remain unknown. The orexin (OX; hypocretin) system is anatomically and functionally positioned to serve as a key mediator of stress-induced neuroplasticity. Indeed, OX neurons receive direct corticotropin-releasing factor (CRF) input from the hypothalamic paraventricular nucleus (PVN) and project broadly to brain regions involved in arousal, motivation, emotional regulation, and reward processing (e.g., mPFC, HIPP, and AMY). Chronic activation of CRF-sensitive OX pathways may therefore sustain OX-dependent hyperarousal beyond the presence of an acute stressor, increasing excitatory drive throughout emotion-regulation circuits. This prolonged activation may contribute to maladaptive plasticity through alterations in neuronal excitability, impaired homeostatic regulation, and reductions in brain-derived neurotrophic factor (BDNF)-related signaling. In this review, we propose a mechanistic framework in which CRF-mediated recruitment of hypothalamic OX neurons contributes to neuroplasticity deficits in the mPFC, HIPP, and AMY. We discuss how developmental stage, biological sex, and genetic variation influence vulnerability to these adaptations and examine therapeutic strategies aimed at reducing hyperarousal and restoring neural plasticity. Collectively, this theoretical framework positions OX transmission as a potential link between chronic stress and mood-related psychopathology.

Read PDF

Similar papers

Open access Oct 2026

Stress-Driven Brain Remodeling in Opioid Use Disorder: Toward a Neuroprogressive Model

Background: Opioid use disorder (OUD) is classically understood through reward dysregulation, opponent processes, and allostatic adaptation, but these models only partly account for the persistent cognitive, affective, and stress-regulatory abnormalities observed in some individuals with long-standing OUD. Methods: Thi...

F. Della Rocca, I. Maremmani, M. Carbone et al. · 0 citations
Open access Oct 2026

Neuronal progranulin in the medial prefrontal cortex mediates stress-induced despair-like behaviors and impaired neuroplasticity.

BACKGROUND Neuroplasticity in the medial prefrontal cortex (mPFC) is critically implicated in major depressive disorder (MDD). Progranulin (PGRN), a multifunctional protein that is abundant in the cortex, regulates neuronal development and synaptic maintenance, positioning it as a candidate therapeutic target for MDD....

Yun-Feng Wang, Yao Yang, Si-Man Guo et al. · 0 citations
Open access Oct 2026

The hypothalamic orexin-medial prefrontal cortex pathway modulates susceptibility to depression in the learned helplessness paradigm in male mice.

Depression is a prevalent psychiatric disorder primarily characterized by behavioral despair and helplessness. The orexinergic system plays a crucial role in stress-induced depression; however, the precise mechanisms remain unclear. The medial prefrontal cortex (mPFC), a major target of orexinergic projections, is esse...

Ting Mi, Zhen-Quan He, Bao-Cong Yu et al. · 0 citations
Review Open access Sep 2026

Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.

Psychedelics (hallucinogenic 5-HT2A agonists such as psilocybin) are being investigated for their potential to treat a range of conditions, including anxiety-related psychopathology. Despite promising results, the mechanisms by which psychedelic therapy may alleviate anxiety are not well understood. Here, we review neu...

Hugh Mcgovern, Nick Wellman, B. Hutchinson et al. · 1 citation
Editorial Sep 2026

Hippocampal mechanisms and neural circuitry of negative symptoms in schizophrenia.

This work proposes a two-dimensional clinical framework for negative symptoms to better understand their neurobiological mechanism, by segregating symptoms into diminished expressivity and amotivation domains and explores how biological sex serves as a critical factor of individual variability in symptom expression.

D. Uliana, Anthony A. Grace · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.